Intuitive Surgical, Inc. (NASDAQ:ISRG) COO Salvatore Brogna sold 2,090 shares of Intuitive Surgical stock in a transaction that occurred on Monday, December 3rd. The shares were sold at an average price of $541.88, for a total transaction of $1,132,529.20. Following the transaction, the chief operating officer now directly owns 2,049 shares in the company, valued at $1,110,312.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

NASDAQ:ISRG opened at $519.09 on Friday. Intuitive Surgical, Inc. has a 12 month low of $359.75 and a 12 month high of $581.12. The firm has a market cap of $59.25 billion, a PE ratio of 72.20, a P/E/G ratio of 3.75 and a beta of 1.03.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 18th. The medical equipment provider reported $2.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.66 by $0.17. Intuitive Surgical had a net margin of 22.31% and a return on equity of 18.79%. The business had revenue of $920.90 million during the quarter, compared to the consensus estimate of $916.22 million. During the same period in the previous year, the firm posted $2.77 earnings per share. The business’s revenue for the quarter was up 14.0% compared to the same quarter last year. Research analysts predict that Intuitive Surgical, Inc. will post 9.52 EPS for the current fiscal year.

Several equities analysts recently issued reports on ISRG shares. Piper Jaffray Companies raised shares of Intuitive Surgical from a “neutral” rating to an “overweight” rating and set a $600.00 price objective on the stock in a report on Tuesday, October 9th. Morgan Stanley lifted their price target on shares of Intuitive Surgical from $575.00 to $600.00 and gave the stock an “overweight” rating in a report on Thursday, October 11th. Wells Fargo & Co lifted their price target on shares of Intuitive Surgical from $575.00 to $635.00 and gave the stock an “outperform” rating in a report on Wednesday, September 12th. Zacks Investment Research lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Thursday, November 29th. Finally, UBS Group started coverage on shares of Intuitive Surgical in a report on Tuesday, November 27th. They issued a “neutral” rating and a $540.00 price target on the stock. One research analyst has rated the stock with a sell rating, six have issued a hold rating and sixteen have given a buy rating to the company. Intuitive Surgical currently has an average rating of “Buy” and a consensus price target of $556.01.

Several large investors have recently bought and sold shares of the company. Marshall Wace North America L.P. lifted its position in Intuitive Surgical by 45.1% during the third quarter. Marshall Wace North America L.P. now owns 67,772 shares of the medical equipment provider’s stock valued at $38,901,000 after purchasing an additional 21,062 shares during the period. Belpointe Asset Management LLC acquired a new position in Intuitive Surgical during the third quarter valued at $342,000. Vanguard Group Inc. lifted its position in Intuitive Surgical by 0.4% during the third quarter. Vanguard Group Inc. now owns 8,313,421 shares of the medical equipment provider’s stock valued at $4,771,903,000 after purchasing an additional 29,260 shares during the period. Morgan Stanley lifted its position in Intuitive Surgical by 119.5% during the third quarter. Morgan Stanley now owns 2,856,195 shares of the medical equipment provider’s stock valued at $1,639,456,000 after purchasing an additional 1,554,896 shares during the period. Finally, Rehmann Capital Advisory Group lifted its position in Intuitive Surgical by 55,900.0% during the third quarter. Rehmann Capital Advisory Group now owns 183,680 shares of the medical equipment provider’s stock valued at $320,000 after purchasing an additional 183,352 shares during the period. Institutional investors and hedge funds own 84.31% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This piece was first reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States and international copyright and trademark law. The original version of this piece can be viewed at https://www.watchlistnews.com/insider-selling-intuitive-surgical-inc-isrg-coo-sells-1132529-20-in-stock/2666583.html.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. The company's da Vinci surgical System translates a surgeon's natural hand movements, which are performed on instrument controls at a console into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Read More: 52-Week High/Low

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.